After seeing some strength earlier on, biotech stocks came under pressure in the week ended Aug. 21. With the earnings season tapering and not much of noise on the coronavirus front, the sector reacted to some clinical readouts, two M&A announcements and a couple of adverse rulings handed down by the FDA.Three biotech issues IPOed this week, collecting a cumulative $404.1 in gross proceeds. This apart, Israeli medical imaging startup Nano-X Imaging Ltd (NASDAQ: NNOX) raised $165.2 million.Here’re the key catalysts for the unfolding week:ConferencesVirtual World Orphan Drug Congress USA 2020: Aug. 24-27 European Association for the …read more
Source:: Yahoo Finance
